Announcements Trials

Browse Landscape

Phase

Status

Recruiting 3 Withdrawn 1 Terminated 1 Enrolling by invitation 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 303 Carcinoma, Non-Small-Cell Lung 240 Prostatic Neoplasms 196 Neoplasms 190 Lung Neoplasms 149 Multiple Myeloma 141 Neoplasm Metastasis 110 Colorectal Neoplasms 104 Melanoma 97 Ovarian Neoplasms 90 Leukemia, Myeloid, Acute 82 Pancreatic Neoplasms 76 Lymphoma 76 Leukemia, Lymphocytic, Chronic, B-Cell 71 Brain Neoplasms 69 Carcinoma, Renal Cell 67 Squamous Cell Carcinoma of Head and Neck 62 Lymphoma, Non-Hodgkin 62 Carcinoma, Hepatocellular 61 Hematologic Neoplasms 60 Urinary Bladder Neoplasms 58 Head and Neck Neoplasms 56 Triple Negative Breast Neoplasms 55 Recurrence 54 Glioblastoma 53 Uterine Cervical Neoplasms 51 Lymphoma, Follicular 51 Endometrial Neoplasms 50 Stomach Neoplasms 46 Sarcoma 46

Interventions

pembrolizumab 1 liposomal doxorubicin 1 1-dodecylpyridoxal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Adenoviridae Infections × 90 days × Clear all

NCT05271318 2026-05-05

PROTA

TILT Biotherapeutics Ltd.

Phase 1/2 Active not recruiting

Adenoviridae Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡